Yasutaka Kimoto

1.5k total citations
62 papers, 1.2k citations indexed

About

Yasutaka Kimoto is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Yasutaka Kimoto has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Rheumatology, 28 papers in Immunology and 11 papers in Genetics. Recurrent topics in Yasutaka Kimoto's work include Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and T-cell and B-cell Immunology (9 papers). Yasutaka Kimoto is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and T-cell and B-cell Immunology (9 papers). Yasutaka Kimoto collaborates with scholars based in Japan, United States and Taiwan. Yasutaka Kimoto's co-authors include Takahiko Horiuchi, Hiroki Mitoma, Hiroshi Tsukamoto, Mine Harada, Yasuhiro Tamimoto, Shin‐ichi Harashima, Koichi Akashi, Hiroaki Niiro, Yojiro Arinobu and Nobuaki Hatta and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yasutaka Kimoto

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutaka Kimoto Japan 19 572 415 195 150 123 62 1.2k
Lilian Soto Chile 18 602 1.1× 387 0.9× 141 0.7× 91 0.6× 155 1.3× 32 1.1k
Angela Midgley United Kingdom 19 543 0.9× 473 1.1× 272 1.4× 152 1.0× 61 0.5× 35 1.1k
P. Martin van Hagen Netherlands 21 457 0.8× 267 0.6× 210 1.1× 175 1.2× 122 1.0× 62 1.2k
Cor L. Verweij Netherlands 12 476 0.8× 233 0.6× 138 0.7× 120 0.8× 115 0.9× 17 1.0k
Ryusuke Yoshimi Japan 23 413 0.7× 653 1.6× 328 1.7× 101 0.7× 148 1.2× 84 1.4k
Odette Viñas Spain 21 318 0.6× 318 0.8× 171 0.9× 337 2.2× 87 0.7× 57 1.3k
Yufeng Yin China 16 279 0.5× 364 0.9× 150 0.8× 104 0.7× 85 0.7× 37 811
Thomas McDonnell United Kingdom 17 337 0.6× 356 0.9× 216 1.1× 96 0.6× 72 0.6× 52 1.1k
Joëlle Goetz France 17 334 0.6× 357 0.9× 134 0.7× 215 1.4× 92 0.7× 58 1.1k
Venkat Reddy United Kingdom 15 732 1.3× 379 0.9× 86 0.4× 84 0.6× 135 1.1× 36 1.2k

Countries citing papers authored by Yasutaka Kimoto

Since Specialization
Citations

This map shows the geographic impact of Yasutaka Kimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutaka Kimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutaka Kimoto more than expected).

Fields of papers citing papers by Yasutaka Kimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutaka Kimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutaka Kimoto. The network helps show where Yasutaka Kimoto may publish in the future.

Co-authorship network of co-authors of Yasutaka Kimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutaka Kimoto. A scholar is included among the top collaborators of Yasutaka Kimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutaka Kimoto. Yasutaka Kimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayano, Masahiro, Akie Hirata, Yasutaka Kimoto, et al.. (2024). No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study. Rheumatology International. 44(11). 2411–2419. 3 indexed citations
2.
3.
Kimoto, Yasutaka, Takuya Sawabe, Masahiro Ayano, et al.. (2022). Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study. Modern Rheumatology. 33(2). 367–372. 9 indexed citations
4.
Kimoto, Yasutaka & Takahiko Horiuchi. (2022). The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs. Frontiers in Immunology. 13. 926044–926044. 21 indexed citations
5.
Mitoma, Hiroki, Yusuke Yamauchi, Masahiro Ayano, et al.. (2022). CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis. Frontiers in Immunology. 13. 1016914–1016914. 8 indexed citations
6.
Arinobu, Yojiro, Kohta Miyawaki, Masahiro Ayano, et al.. (2021). Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis. Medicine. 100(13). e25406–e25406. 8 indexed citations
7.
Ayano, Masahiro, Ken Yamamoto, Kōji Takayama, et al.. (2021). Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis. Journal of Neuroimmunology. 357. 577631–577631. 2 indexed citations
8.
Ayano, Masahiro, Yasutaka Kimoto, Hiroki Mitoma, et al.. (2021). Human PD-1hiCD8+ T Cells Are a Cellular Source of IL-21 in Rheumatoid Arthritis. Frontiers in Immunology. 12. 654623–654623. 23 indexed citations
9.
Miyawaki, Kohta, Masahiro Ayano, Yasutaka Kimoto, et al.. (2020). Type 1 helper T cells generate CXCL9/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis. Cellular Immunology. 360. 104263–104263. 22 indexed citations
10.
Ayano, Masahiro, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2019). CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Arthritis Research & Therapy. 21(1). 30–30. 26 indexed citations
11.
Kiyohara, Chikako, Takuya Sawabe, Shuji Nagano, et al.. (2018). Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study. PLoS ONE. 13(4). e0196368–e0196368. 44 indexed citations
12.
Arinobu, Yojiro, Koichi Akashi, Koh‐Hei Sonoda, et al.. (2017). Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease. European Journal of Rheumatology. 5(1). 9–15. 10 indexed citations
13.
Kimoto, Yasutaka, et al.. (2014). Pleuritis Clinically Diagnosed as Aspergillosis during the Course of Microscopic Polyangiitis. Internal Medicine. 53(24). 2821–2824. 3 indexed citations
14.
Kiyohara, Chikako, Takahiko Horiuchi, Hiroshi Tsukamoto, et al.. (2013). Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus. Modern Rheumatology. 23(4). 765–773. 9 indexed citations
15.
Kiyohara, Chikako, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2009). Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatology International. 31(3). 365–376. 13 indexed citations
16.
Sakaguchi, Donald S., Chikako Kiyohara, Hiroshi Tsukamoto, et al.. (2008). Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Lara D. Veeken. 47(2). 158–164. 50 indexed citations
17.
Horiuchi, Takahiko, Chikako Kiyohara, Takuya Sawabe, et al.. (2006). A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case–control study and a meta-analysis. Annals of the Rheumatic Diseases. 66(3). 320–324. 40 indexed citations
18.
Kimoto, Yasutaka. (1998). Glucagon relaxes the isolated rabbit corpus cavernosum penis precontracted by noradrenaline. International Journal of Impotence Research. 10(4). 264–264.
19.
Kimoto, Yasutaka & Yushi Ito. (1988). Functional Innervation Patterns in the Corpus Spongiosum and Glans in the Dog. British Journal of Urology. 62(6). 597–602. 2 indexed citations
20.
Kimoto, Yasutaka & Yushi Ito. (1987). Autonomic Innervation of the Canine Penile Artery and Vein in Relation to Neural Mechanisms Involved in Erection. British Journal of Urology. 59(5). 463–472. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lilian Soto Breakdown of academic impact, for papers by Angela Midgley Breakdown of academic impact, for papers by P. Martin van Hagen Breakdown of academic impact, for papers by Cor L. Verweij Breakdown of academic impact, for papers by Ryusuke Yoshimi Breakdown of academic impact, for papers by Odette Viñas Breakdown of academic impact, for papers by Yufeng Yin Breakdown of academic impact, for papers by Thomas McDonnell Breakdown of academic impact, for papers by Joëlle Goetz Breakdown of academic impact, for papers by Venkat Reddy
Rankless by CCL
2026